The concept of value is expanding beyond the traditional payer focus. In this micro-tutorial, we describe expanded value drivers that payers now consider, and how to address the challenges of incorporating them into payer/HTA frameworks and generating robust supporting evidence.
Tutors
Content
Audience
To schedule a meeting to discuss this work, please contact our experts.
Jump to a slide with the slide dots.
Insights from ASH® 2025 on hematology innovation, CAR-T, bispecifics, diagnostics, and how connected strategy supports real-world adoption.
Read moreWhy Alzheimer’s DMT uptake remains low: Explore key barriers, diagnostic gaps, and market insights from 783 physicians worldwide.
Read moreAgentic AI–powered launch command centers predict pharma launch risks and enable faster, smarter decisions for successful product launches.
Read more